MONALISA Ultra
MONALISA Cross-Linked Hyaluronic Acid Dermal Filler
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- South Korea
- Payment Terms
- Others,T/T
- Production method
- Available
- Shipping / Lead Time
- Negotiable / Negotiable
- Keyword
- dermal filler, filler, korean filler, monalisa ultra
- Category
- Other Beauty Equipment
Celset Co., Ltd.
- Membership
- PRO
- Recent Visit
- Nov 06, 2024
- Country / Year Established
- South Korea /
- Business type
- Others
- Verified Certificate
-
2
Product name | MONALISA Ultra | Certification | - |
---|---|---|---|
Category | Other Beauty Equipment | Material | - |
Keyword | dermal filler , filler , korean filler , monalisa ultra | Unit Size | - |
Brand name | - | Unit Weigh | - |
origin | South Korea | Stock | 1000 |
Supply type | Available | HS code | - |
Product Information
MONALISA Cross-Linked Hyaluronic Acid Dermal Filler
1.Volume Effect and Retention
The uniform sized hyaluronic acid particles with optimal viscoelasticity can maintain a long-lasting volume.
2.Safe to Use on Patients
MONALISA is safe to use on patients due to low level of endotoxin and essentially no BDDE residue
3.Easy Procedural Operation
The ergonomically-designed rod and grip allow the even distribution of pressure during the injection to enable an accurate and safe treatment for both the clinician and the patient.
4. Highly Pure Hyaluronic Acid
This is gained by implementing a strict quality control system through direct involvement in the entire production process from the base material of hyaluronic acid to the final product.
5.Global Standard Quality Control
To guarantee the quality of MONALISA, the producer strictly fulfills and complies with the international quality regulations, including CE, KGMP, ISO 13485 and ISO 9001.
Hy-BRID technology enables the production of highly dense and uniform particles in MONALISA.
The volume is maintained for at least 6 months before the dissolution process begins.
– Granular cross-linked hyalruronic acid improves wrinkles temporarily.
– Hyaluronic acid has a high bio-compatibility.
Designed to Give Comfort
MONALISA Filler’s pushrod and handle are designed to enable the user to insert it for an operation with a less effort.
The handle design is developed to fit various sizes of hands and prevent slipping.
*CE acquired/marked
Concentration: HA 24mg/ml
Appearance: No impurities, transparent and colorless gel
Composition: Cross-linked hyaluronic acid
Syringe Volume: 1.0mL
Storage : 2~25C
MONALISA Cross-Linked Hyaluronic Acid Dermal Filler
1.Volume Effect and Retention
The uniform sized hyaluronic acid particles with optimal viscoelasticity can maintain a long-lasting volume.
2.Safe to Use on Patients
MONALISA is safe to use on patients due to low level of endotoxin and essentially no BDDE residue
3.Easy Procedural Operation
The ergonomically-designed rod and grip allow the even distribution of pressure during the injection to enable an accurate and safe treatment for both the clinician and the patient.
4. Highly Pure Hyaluronic Acid
This is gained by implementing a strict quality control system through direct involvement in the entire production process from the base material of hyaluronic acid to the final product.
5.Global Standard Quality Control
To guarantee the quality of MONALISA, the producer strictly fulfills and complies with the international quality regulations, including CE, KGMP, ISO 13485 and ISO 9001.
Hy-BRID technology enables the production of highly dense and uniform particles in MONALISA.
The volume is maintained for at least 6 months before the dissolution process begins.
– Granular cross-linked hyalruronic acid improves wrinkles temporarily.
– Hyaluronic acid has a high bio-compatibility.
Designed to Give Comfort
MONALISA Filler’s pushrod and handle are designed to enable the user to insert it for an operation with a less effort.
The handle design is developed to fit various sizes of hands and prevent slipping.
*CE acquired/marked
Concentration: HA 24mg/ml
Appearance: No impurities, transparent and colorless gel
Composition: Cross-linked hyaluronic acid
Syringe Volume: 1.0mL
Storage : 2~25C
B2B Trade
Price (FOB) | Negotiable | transportation | Negotiation Other |
---|---|---|---|
MOQ | Negotiable | Leadtime | Negotiable |
Payment Options | Others,T/T | Shipping time | Negotiable |
- President
- Product Category
- Medical Devices
- Main Markets
-
Indonesia
Philippines
Russia
Thailand
- Main Product